Friday - March 29, 2019

CVBD World Forum discuss a changing world in vector-borne Diseases

The 14th CVBD™ (Companion Vector-Borne Diseases) World Forum welcomed parasitologists, veterinary clinicians and epidemiology experts from around the world to discuss changing parasite and vector distributions in a changing world. / Latest data about spread and prevalence of VBDs from endemic to non-endemic regions & need for vets to be equipped with this data
In vet practices across the world, pets are displaying signs of diseases that are non-endemic to their region, requiring vets to treat diseases they never have been exposed to before.

Monheim, Germany, March 29, 2019 – Global parasitologists, veterinary clinicians and epidemiologists have joined together for the 14th CVBD World Forum, held in Trieste, Italy, to discuss the ever-changing global threat of CVBD’s and how veterinary professionals around the world can respond.

In certain areas, the spread of disease carrying vectors is faster than previously recorded, with multiple factors influencing the epidemiology of companion vector-borne diseases around the world. These factors include climate change and weather, wildlife habits and an increase in the importing and travel of pets between countries.

Nick Ogden, Senior Research Scientist at Public Health Agency of Canada, said: “Vector-borne diseases are recognised as being particularly sensitive to weather and climate, so it is expected that climate change will affect where and when vector-borne disease risks occur, and the level of risk they pose to human and animal health.”

Within the forum’s overall theme of ‘Changing parasite and vector distributions in a changing world’, the spread of CVBDs to non-endemic regions, difficulties in diagnosis and treatment and the worrying zoonotic risk posed by certain vectors and pathogens were key discussion points.

Speaking at the forum, Barbara Kohn, Professor at the Clinic for small animals at Freie Universität Berlin, highlighted imported pets as a major concern: "We are seeing more and more cases of diseases in areas where they had not previously been found. Dogs imported from endemic areas are of particular concern for the spread of a disease." The group also explored veterinary strategies to help prevent the spread of disease, including biosecurity, pet owner education and the importance of prevention with anti-vector 'no bite' products.

Veterinary professionals need to be aware and prepared for the arrival of non-endemic diseases in their region, but also clear on their role in helping prevent the spread of disease and in safeguarding their patients’ health.

Ian Wright, ESCCAP, discussed the role that veterinarians play in preventing the spread of vector borne diseases: “Vets have an active role in helping prevent the spread of vector-borne diseases in their area, through early detection via screening imported pets for VBD’s and vigilance for relevant clinical signs in traveled pets. Vets must also ensure accurate parasite and vector prevention advice is communicated to owners, based on the latest distribution data, and encouragement of tick surveillance on pets by owners.”

“It is crucial that we raise awareness of this as vigilance, testing and rapid protective measures are vital in helping to prevent spread. Equally important, vets have to be aware of new parasites/vectors in their country and ready for the possibility of exotic parasites arriving. I would argue it is the defining challenge of our veterinary generation!”

As vector-borne diseases become more widespread and prevalent, through a changing climate and increasing mobility of people and pets around the world, it is more important than ever to exchange knowledge and increase veterinary awareness regarding specific regional risks.

Bayer Animal Health is committed to supporting the scientific knowledge development of CVBDs through collaboration with global organisations, thought leaders and veterinarians.

Veterinarians can access the latest knowledge and information about the most prevalent vectors and diseases by visiting

Read the blog posts online:

About CVBD™ (Companion Vector-Borne Diseases) World Forum
Bayer Animal Health has continuously invested in raising awareness and education levels about Companion Vector-Borne Diseases (CVBDs) to protect dogs and cats around the world from harmful diseases. Every year, Bayer Animal Health brings together a global group of internationally renowned scientists to discuss latest findings and insights from research related to CVBDs.

About Companion Vector-Borne Diseases (CVBD™)
Companion vector-borne diseases (CVBD) are diseases that are transmitted by blood-feeding ectoparasites, including ticks (Lyme disease, babesiosis, ehrlichiosis, anaplasmosis, and hemoplasmosis), fleas (bartonellosis and rickettsiosis), and sand flies (leishmaniosis). They are a known health hazard to animals and humans around the world.

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to

Find more information at

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Download Center
file(s) collected

View Download Center